Enrolling By Invitation NA INTERVENTIONAL 2-arm NCT07036952

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Randomized Double-Blind, Placebo-Controlled Trial

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Conditions PCOS (Polycystic Ovary Syndrome)

Interventions Omega -3 fatty acids Omega 3 fatty acids

Updated 2 times since 2025 Last updated: Jul 22, 2025 Started: Apr 22, 2025 Primary completion: Oct 30, 2025 Completion: Dec 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07036952, this NA trial focuses on PCOS (Polycystic Ovary Syndrome) and remains ongoing. Sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Enrolling By Invitation NA

Status: Not Yet Recruiting → Enrolling By Invitation · Phase: PHASE2 → NA
Jul 2025 — Aug 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Apr 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Data source: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh